Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.(Source : 202003 Annual Report
Aurobindo Pharma Ltd Q2FY25; 9% rise in Profits
Categories
pharma
Laurus Labs Ltd Q4 FY24 Earnings Conference Call Insights
Key highlights from Laurus Labs Ltd (LAURUSLABS) Q4 FY24 Earnings Concall R&D Progress Advanced several pipeline projects across offerings and augmented technology/manufacturing
Gland Pharma Ltd Q3FY24; 17% fall in Profits
Established in Hyderabad, India in 1978, Gland Pharma has grown over the years from a contract manufacturer of small volume liquid parenteral
EPL Ltd Q3FY24; 38% rise in Profits
EPL Limited (formerly known as Essel Propack Limited),is the largest specialty packaging global company, manufacturing laminated plastic tubes catering to the Beauty
Balaji Amines Ltd Q3FY24; 33% fall in Profits
Balaji Amines Ltd specialises in manufacturing Methylamines, Ethylamines, Derivatives of specialty chemicals and Pharma Excipients. These have been the main products, it
Ajanta Pharma Ltd Q3FY24; 56% rise in Profits
Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages.(Source : 202003-01 Annual Report Page No:70).
Laurus Labs Limited Q3 FY24 Earnings Conference Call Insights
Key highlights from Laurus Labs Limited (LAURUSLABS) Q3 FY24 Earnings Concall Business Performance Gross margins remained resilient at over 52% for several
Orchid Pharma Ltd Q2FY24; 21% rise in Revenue
Orchid Pharma is a pharmaceutical company engaged in the development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It
Dr. Reddy’s Laboratories Q4 FY23 Earnings Conference Call Insights
Key highlights from Dr. Reddy's Laboratories (DRREDDY) Q4 FY23 Earnings Concall Q&A Highlights: [00:21:55] Mikhaila at Barclays asked more details about the
Laurus Labs Q3FY23 net profit rises by 32 percent
Pharmaceutical and biotechnology company Laurus Labs reported 32% year-on-year (YoY) rise in profit after tax to INR 203 crore for the quarter
Earnings Summary Of HLE Glascoat Limited For Q3 FY23
HLE Glascoat Limited (NSE: HLEGLAS) is a leading Indian manufacturer of glass-lined equipment for the pharmaceutical and chemical industries. The company's product
Sequent Scientific Limited (SEQUENT) Q3 FY23 Earnings Concall Transcript
Sequent Scientific Limited (NSE:SEQUENT) Q3 FY23 Earnings Concall dated Feb. 15, 2023. Corporate Participants: Abhishek Singhal -- Investor Relations Rajaram Narayanan -- Managing Director P.V. Raghavendra
Cipla Limited (CIPLA) Q3 FY23 Earnings Concall Transcript
Cipla Limited (NSE: CIPLA) Q3 FY23 Earnings Concall dated Jan. 25, 2023 Corporate Participants: Ankit Bhembre -- Investor Relations Ashish Adukia -- Global Chief Financial Officer
Cipla Limited (CIPLA) Q2 FY23 Earnings Concall Transcript
Cipla Limited (NSE: CIPLA) Q2 FY23 Earnings Concall dated Nov. 04, 2022 Corporate Participants: Naveen Bansal -- Head of Investor Relations Ashish Adukia -- Global Chief
Infographic : Gland Pharma Ltd (NSE : GLAND) Q2 Results; Total Revenue = ₹ 1110.28 million ( UP 19.7 % QoQ)
Established in Hyderabad, India in 1978, Gland Pharma has grown over the years from a contract manufacturer of small volume liquid parenteral
Zydus Lifesciences Ltd Q1 FY23 Earnings Conference Call Insights
https://youtu.be/R4mbpNYrIhE Key highlights from Zydus Lifesciences Ltd (ZYDUSLIFE) Q1 FY23 Earnings Concall Q&A Highlights: Neha enquired about the drivers of strong growth
Aurobindo Pharma Limited Q1 FY 2023 Research Tear Sheet
Stock Data Ticker: AUROPHARMA Exchange :NSE and BSE Industry: Automobile Price Performance Last 7 days 4.36% YTD -19.19% Last 12 months -28.17%
Cipla Limited (CIPLA) Q1 FY23 Earnings Concall Transcript
Cipla Limited (NSE:CIPLA) Q1 FY23 Earnings Concall dated Jul. 29, 2022 Corporate Participants: Naveen Bansal -- Head of Investor Relations Umang Vohra
Gland Pharma Ltd Research Tear Sheet Q1 FY 23
Gland Pharma Ltd is an Indian Pharmaceutical company. It was established in 1978, at Hyderabad, India. The founder is PVN Raju. It has
Cipla Q4 FY2022 Research Summary
Cipla is an Indian multinational pharmaceutical company. The company was incorporated in the year 1935. The founder is Khwaja Abdul Hamied. Cipla
Sun Pharmaceuticals Industries Ltd. Q4 FY 2022 Research Summary
Overview Sun Pharmaceutical Industries Limited is an Indian pharmaceutical company. The headquarters is situated in Mumbai, Maharashtra. It was incorporated in 1983.